 |
24 Diseases |  |
12 Trials |
|
12 Trials |  |
871 News |  |
| «12345678910111213 |
- |||| brivaracetam / Generic mfg.
Trial primary completion date: This Trial, Evaluating the Long-term Safety and Tolerability of Brivaracetam Will Provide Subjects Suffering From Epilepsy, Who May Have Benefited From Brivaracetam as Adjunctive Treatment, the Opportunity to Receive Open Label Brivaracetam Treatment (clinicaltrials.gov) - Jun 1, 2016
P3, N=668, Active, not recruiting, Sponsor: UCB PHARMA Inc. (US)
Trial primary completion date: Dec 2017 --> Dec 2016
- brivaracetam / Generic mfg.
Trial completion, Enrollment change: A Brain Imaging Study With Positron Emission Tomography and the Radiotracer [11C]UCB-J to Estimate How Fast Brivaracetam and Levetiracetam Enter the Brain in Healthy Volunteers (clinicaltrials.gov) - May 13, 2016
P1, N=9, Completed, Sponsor: UCB Biopharma S.P.R.L.
Trial primary completion date: Dec 2017 --> Dec 2016 Recruiting --> Completed | N=12 --> 9
- ||| brivaracetam / Generic mfg.
New trial: BASE: Study to Look at How Effective Briviact is as add-on Treatment for Patients With Epilepsy With Partial Onset Seizures (clinicaltrials.gov) - Feb 22, 2016
P=N/A, N=430, Recruiting, Sponsor: UCB Biopharma S.P.R.L.
- | brivaracetam / Generic mfg.
Enrollment change: Evaluation of Long-term Safety, and Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects With Epilepsy (clinicaltrials.gov) - Jan 15, 2016
P3, N=26, Active, not recruiting, Sponsor: UCB Pharma SA
Recruiting --> Completed | N=12 --> 9 N=650 --> 26
- brivaracetam / Generic mfg.
Enrollment open: A Brain Imaging Study With Positron Emission Tomography and the Radiotracer [11C]UCB-J to Estimate How Fast Brivaracetam and Levetiracetam Enter the Brain in Healthy Volunteers (clinicaltrials.gov) - Dec 10, 2015
P1, N=12, Recruiting, Sponsor: UCB Biopharma S.P.R.L.
N=650 --> 26 Not yet recruiting --> Recruiting
- | brivaracetam / Generic mfg.
New P1 trial: A Brain Imaging Study With Positron Emission Tomography and the Radiotracer [11C]UCB-J to Estimate How Fast Brivaracetam and Levetiracetam Enter the Brain in Healthy Volunteers (clinicaltrials.gov) - Nov 14, 2015
P1, N=12, Not yet recruiting, Sponsor: UCB Biopharma S.P.R.L.
- |||| brivaracetam / Generic mfg.
Trial primary completion date: This Trial, Evaluating the Long-term Safety and Tolerability of Brivaracetam Will Provide Subjects Suffering From Epilepsy, Who May Have Benefited From Brivaracetam as Adjunctive Treatment, the Opportunity to Receive Open Label Brivaracetam Treatment (clinicaltrials.gov) - Aug 13, 2015
P3, N=668, Active, not recruiting, Sponsor: UCB Pharma
Not yet recruiting --> Recruiting Trial primary completion date: Jun 2015 --> Dec 2017
- brivaracetam / Generic mfg.
Trial primary completion date: BRITE: Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Epilepsy (clinicaltrials.gov) - Jun 11, 2015
P3, N=820, Active, not recruiting, Sponsor: UCB Pharma
Trial primary completion date: Jun 2015 --> Dec 2017 Trial primary completion date: Jun 2015 --> Nov 2016
- brivaracetam / Generic mfg.
Trial primary completion date: An Open-label, Multinational, Multicenter, Follow-up Study to Evaluate the Long-term Safety and Efficacy of Brivaracetam (clinicaltrials.gov) - May 4, 2015
P3, N=108, Active, not recruiting, Sponsor: UCB Pharma
Trial primary completion date: Jun 2015 --> Nov 2016 Trial primary completion date: Jun 2015 --> Dec 2017
- phenytoin / Generic mfg., brivaracetam / Generic mfg.
Enrollment change, Trial termination, Trial primary completion date: Efficacy Evaluation of Intravenous Brivaracetam and Phenytoin in Subjects With Nonconvulsive Electrographic Seizures (clinicaltrials.gov) - Dec 17, 2014
P2, N=1, Terminated, Sponsor: UCB BIOSCIENCES, Inc.
N=50 --> 1 | Recruiting --> Terminated | Trial primary completion date: Aug 2016 --> Oct 2014; Termination of study due to low enrollment. There were no safety issues.
- ||||| brivaracetam / Generic mfg.
Enrollment closed: Evaluation of Long-term Safety, and Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects With Epilepsy (clinicaltrials.gov) - Oct 2, 2014
P3, N=650, Active, not recruiting, Sponsor: UCB Pharma SA
There were no safety issues. Recruiting --> Active, not recruiting
- phenytoin / Generic mfg., brivaracetam / Generic mfg.
Trial primary completion date: Efficacy Evaluation of Intravenous Brivaracetam and Phenytoin in Subjects With Nonconvulsive Electrographic Seizures (clinicaltrials.gov) - Aug 1, 2014
P2, N=50, Recruiting, Sponsor: UCB BIOSCIENCES, Inc.
Recruiting --> Active, not recruiting Trial primary completion date: Feb 2017 --> Aug 2016
- phenytoin / Generic mfg., brivaracetam / Generic mfg.
Trial primary completion date: Efficacy Evaluation of Intravenous Brivaracetam and Phenytoin in Subjects With Nonconvulsive Electrographic Seizures (clinicaltrials.gov) - Jul 15, 2014
P2, N=50, Recruiting, Sponsor: UCB BIOSCIENCES, Inc.
Trial primary completion date: Feb 2017 --> Aug 2016 Trial primary completion date: Jun 2015 --> Feb 2017
- | phenytoin / Generic mfg., brivaracetam / Generic mfg.
Enrollment open: Efficacy Evaluation of Intravenous Brivaracetam and Phenytoin in Subjects With Nonconvulsive Electrographic Seizures (clinicaltrials.gov) - Jun 4, 2014
P2, N=50, Recruiting, Sponsor: UCB BIOSCIENCES, Inc.
Trial primary completion date: Jun 2015 --> Feb 2017 Not yet recruiting --> Recruiting
- | phenytoin / Generic mfg., brivaracetam / Generic mfg.
Trial initiation date: Efficacy Evaluation of Intravenous Brivaracetam and Phenytoin in Subjects With Nonconvulsive Electrographic Seizures (clinicaltrials.gov) - Jun 4, 2014
P2, N=50, Not yet recruiting, Sponsor: UCB BIOSCIENCES, Inc.
Not yet recruiting --> Recruiting Initiation date: May 2014 --> Jun 2014
- ||||||| brivaracetam / Generic mfg.
Trial completion: BRITE: Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures (clinicaltrials.gov) - May 28, 2014
P3, N=768, Completed, Sponsor: UCB, Inc.
Initiation date: May 2014 --> Jun 2014 Active, not recruiting --> Completed
- ||||| brivaracetam / Generic mfg.
Enrollment closed: BRITE: Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Epilepsy (clinicaltrials.gov) - May 27, 2014
P3, N=820, Active, not recruiting, Sponsor: UCB, Inc.
Active, not recruiting --> Completed Enrolling by invitation --> Active, not recruiting
- | phenytoin / Generic mfg., brivaracetam / Generic mfg.
New P2 trial: Efficacy Evaluation of Intravenous Brivaracetam and Phenytoin in Subjects With Nonconvulsive Electrographic Seizures (clinicaltrials.gov) - Mar 13, 2014
P2, N=50, Not yet recruiting, Sponsor: UCB BIOSCIENCES, Inc.
- || brivaracetam / Generic mfg.
Trial completion, Adverse events: Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV) (clinicaltrials.gov) - Nov 27, 2013
P3, N=29, Completed, Sponsor: UCB Pharma SA
Enrolling by invitation --> Active, not recruiting Recruiting --> Completed
- | brivaracetam / Generic mfg.
Trial completion: Comparison of Brivaracetam Oral Tablet (10 mg, 50 mg, 75 mg and 100 mg) and Brivaracetam Injection (100 mg) in Healthy Volunteers (clinicaltrials.gov) - Apr 11, 2013
P1, N=25, Completed, Sponsor: UCB Pharma SA
Recruiting --> Completed Active, not recruiting --> Completed
- brivaracetam / Generic mfg.
Trial completion: Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy. (clinicaltrials.gov) - Mar 28, 2013
P2, N=101, Completed, Sponsor: UCB, Inc.
Active, not recruiting --> Completed Recruiting --> Completed
- ||||| brivaracetam / Generic mfg.
Enrollment change: Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy (clinicaltrials.gov) - Mar 7, 2013
P3, N=600, Enrolling by invitation, Sponsor: UCB, Inc.
Recruiting --> Completed N=500 --> 600
- | brivaracetam / Generic mfg.
New P1 trial: Comparison of Brivaracetam Oral Tablet (10 mg, 50 mg, 75 mg and 100 mg) and Brivaracetam Injection (100 mg) in Healthy Volunteers (clinicaltrials.gov) - Feb 20, 2013
P1, N=25, Completed, Sponsor: UCB Pharma SA
- | brivaracetam / Generic mfg.
Trial completion: A Study to Investigate the Drug-Drug Interactions of Brivaracetam and Ethanol in Healthy Male Subjects (clinicaltrials.gov) - Dec 9, 2012
P1, N=18, Completed, Sponsor: UCB Pharma SA
N=500 --> 600 Active, not recruiting --> Completed
- |||||||||| brivaracetam / Generic mfg.
New P3 trial: Evaluation of Long-term Safety, and Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects With Epilepsy (clinicaltrials.gov) - Nov 14, 2012
P3, N=650, Recruiting, Sponsor: UCB Pharma SA
- | brivaracetam / Generic mfg.
New P1 trial: A Study to Investigate the Drug-Drug Interactions of Brivaracetam and Ethanol in Healthy Male Subjects (clinicaltrials.gov) - Oct 17, 2012
P1, N=18, Completed, Sponsor: UCB Pharma SA
- ||||||| brivaracetam / Generic mfg.
Trial completion: Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy (clinicaltrials.gov) - Aug 19, 2012
P3, N=105, Completed, Sponsor: UCB, Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||| brivaracetam / Generic mfg.
New P3 trial, Adverse events: Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV) (clinicaltrials.gov) - Jul 26, 2012
P3, N=29, Completed, Sponsor: UCB Pharma SA
- | brivaracetam / Generic mfg.
Enrollment change: An Open-label, Multinational, Multicenter, Follow-up Study to Evaluate the Long-term Safety and Efficacy of Brivaracetam (clinicaltrials.gov) - Jan 17, 2012
P3, N=108, Active, not recruiting, Sponsor: UCB, Inc.
Active, not recruiting --> Completed N=600 --> 108